Top Markets
#1 Derive Derive +30.44%
#2 Audiera Audiera +15.71%
#3 Geodnet Geodnet +14.67%
#4 Cross Cross +14.12%
#5 Humanity Humanity +11.02%
#6 Biconomy Biconomy +10.85%
#7 The Bitcoin Bull The Bitcoin Bull +9.78%
#8 Cap Cap +9.36%
#9 Based Based +8.40%
#10 Quack AI Quack AI +7.88%
Coin of the day
Derive Derive
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Dogwood Therapeutics, Inc. Dogwood Therapeutics, Inc.

Dogwood Therapeutics, Inc.

DWTX
Classificação em ações #35719
Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to... Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions provoked by viral infections. Its leading therapeutic candidate, IMC-1, is a precise fixed-dose combination of famciclovir and celecoxib, engineered to combat fibromyalgia. Additionally, the company is advancing IMC-2, which blends valacyclovir and celecoxib, aiming to alleviate the array of symptoms linked to long COVID, including persistent fatigue, sleep disturbances, cognitive issues, pain, autonomic dysfunction, and anxiety. Previously operating as Virios Therapeutics, Inc., the organization adopted the name Dogwood Therapeutics, Inc. in October 2024. Established in 2012, the company maintains its main office in Alpharetta, Georgia.
Preço da ação
$1.84
Última sincronização: 2026-08-11
Valor de mercado
$3.51M
Variação (1 dia)
0.46%
Variação (1 ano)
-62.71%
País
US
Negociar Dogwood Therapeutics, Inc. (DWTX)

Categoria

Healthcare
Histórico de preços das ações de Dogwood Therapeutics, Inc. (DWTX)
Preço de fecho mais alto: $1.81 em 2026-08-01

Preço de fecho mais baixo: $241.05 em 2020-12-01
Histórico de preços das ações da Dogwood Therapeutics, Inc. de 2020 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -37.58%
2025 122.27%
2024 -84.09%
2023 144.93%
2022 -94.85%
2021 -47.68%
2020 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE